Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Immediate Abundant Intravenous Normal Saline Infusion for Stroke After Intravenous Thrombolysis: a Multi-centre Randomized Controlled Phase III Trial

NCT07497542 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.

NCT NCT07497542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07497542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Immediate Abundant Intravenous Normal Saline Infusion for Stroke After Intravenous Thrombolysis: a Multi-centre Randomized Controlled Phase III Trial
Lead sponsor
Tianjin Medical University General Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
September 30, 2029
Enrollment
752 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain infarction